Drug Type Small molecule drug |
Synonyms L 669262, L-669262 |
Target |
Action inhibitors |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H36O6 |
InChIKeyNPDFVGFXQSJBAA-ZBDDBYLNSA-N |
CAS Registry130468-11-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Preclinical | - | - |





